What we achieved in 2025, together
Date
Research news
Date
We achieved so much in 2025. And it’s all thanks to your support.
Date
Early results from a study of the drug developed by AC Immune offer hope that it could slow the progression of Parkinson's symptoms.
Date
A small clinical trial of a probiotic called Symprove shows it helps with non-motor symptoms of Parkinson’s, changes gut bacteria and improves efficiency of medication.
Date
Today we publish new statistics about Parkinson’s in the UK, highlighting gaps in NHS services.
Date
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
Date
HER-096, a potential new Parkinson's treatment, has shown promising phase 1 trial results, proving it’s safe, well-tolerated, and effective in reaching the brain in people with Parkinson's. This is a crucial step towards a drug that could slow, stop, or even repair Parkinson's damage.
Date
As the leading funder of Parkinson’s research in Europe, we’re pleased to announce that we’re supporting new projects that hope to bring us closer to better treatments to transform the lives of those affected by Parkinson’s.
Date
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.
Date
Thanks to our crucial funding, a new drug treatment, created by NRG Therapeutics, is moving forwards.
Date
The UK government has published its 10 Year Health Plan for England. We look at what this may mean for people with Parkinson’s and what we think needs to happen next.